Early Data Link Diet Drug toMI, Stroke, and Cardiac Death

WASHINGTON (MedPage Today) Preliminary analysis of data from a placebo-controlled study of sibutramine (Meridia) suggest an excess risk of cardiovascular events including myocardial infarction and cardiac death among patients taking the diet drug, according to the FDA.

source : www.medpagetoday.com

Related News:

• Kidney Cancer Drug Shows Promising Results
• AM: Drug for Fibromyalgia Boosts Multiple Outcomes (CME/CE)
• Access Pharmaceuticals Initiates Program Applying Cobalamin Platform To SiRNA Drug Delivery
• Auxilium Announces U.S. Food And Drug Administration Approval For XIAFLEXTM For The Treatment Of Dupuytren’s Contracture
• Possible New Drug Target For Iron Deficiency, Overload
• Targeted Oral Drug Pazopanib Slows Progression Of Advanced Kidney Cancer
• Using Zebrafish As A Novel Platform For Drug Development
• PSivida CEO To Discuss Ocular Drug Delivery In Diabetic Retinopathy At 6th Annual Diabetes Conference January 22 In London
• Abnormal Lipid Levels Common in Teens
• FDA Adds Cardio Warnings to Weight Loss Drug

Details :
Submited at Sunday, November 22nd, 2009 at 1:00 am on Cardiology by Gillan
Comment RSS 2.0 - leave a comment - trackback